Return to Listing

1 result(s) for

PI Name Protocol # Title
Jeremy Cetnar STUDY00019505 A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080